Recent Company News

• 09:17 AM ET Feb 02, 2026
  

  Transcript Intelligence: Molecular Partners Business Update Call

• 01:06 AM ET Feb 02, 2026
  

  Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 (CHF 3.28, 0.00)

• 06:16 AM ET Jan 27, 2026
  

  Molecular Partners initiated buy at HC Wainwright ($4.00, 0.00)

• 02:47 PM ET Jan 15, 2026
  

  Transcript Intelligence: Molecular Partners at J.P. Morgan Healthcare Conference (CHF3.26, 0.00)

• 03:11 PM ET Jan 11, 2026
  

  Molecular Partners provides update which it will present tomorrow at the JPMorgan Healthcare Conference (CHF 3.30, 0.00)

• 07:02 AM ET Dec 11, 2025
  

  Molecular Partners forms scientific advisory board to accelerate development of targeted radiotherapeutics (CHF 3.45, +0.11)

• 10:32 AM ET Dec 07, 2025
  

  Molecular Partners to present updated data from Phase 1/2a trial of MP0533 at ASH Annual Meeting (CHF 3.39, 0.00)

• 04:08 AM ET Nov 04, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 09:20 AM ET Nov 03, 2025
  

  StreetAccount Summary - US Pre-market trading update